Since CD8 T cells were essential for treatment efficacy and individual mice harbor a stochastically generated TCR repertoire via random V(D)J recombination, we next examined whether the differences in the TCR repertoire of CD8 TILs may correlate to the heterogeneous responses to anti-PD-L1 in different tumor-bearing mice. The gene discussed is CD8A; the disease is neoplasm.